Jamjoom Pharmaceuticals Factory Company (TADAWUL: 4015)

Jamjoom Pharmaceuticals Factory Company Statistics

Total Valuation

Jamjoom Pharmaceuticals Factory Company has a market cap or net worth of SAR 10.58 billion. The enterprise value is 10.46 billion.

Market Cap	10.58B
Enterprise Value	10.46B

Important Dates

The next estimated earnings date is Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	Aug 18, 2024

Share Statistics

Jamjoom Pharmaceuticals Factory Company has 70.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	70.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	70.00%
Owned by Institutions (%)	2.43%
Float	21.00M

Valuation Ratios

The trailing PE ratio is 30.29 and the forward PE ratio is 25.44. Jamjoom Pharmaceuticals Factory Company's PEG ratio is 1.59.

PE Ratio	30.29
Forward PE	25.44
PS Ratio	8.35
PB Ratio	7.33
P/TBV Ratio	7.39
P/FCF Ratio	41.57
P/OCF Ratio	n/a
PEG Ratio	1.59

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.83, with an EV/FCF ratio of 41.10.

EV / Earnings	29.95
EV / Sales	8.25
EV / EBITDA	24.83
EV / EBIT	27.01
EV / FCF	41.10

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.00.

Current Ratio	3.34
Quick Ratio	2.43
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	3,564.38

Financial Efficiency

Return on equity (ROE) is 24.90% and return on invested capital (ROIC) is 16.51%.

Return on Equity (ROE)	24.90%
Return on Assets (ROA)	13.20%
Return on Capital (ROIC)	16.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.72
Inventory Turnover	2.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+28.77%
50-Day Moving Average	155.76
200-Day Moving Average	153.98
Relative Strength Index (RSI)	43.05
Average Volume (20 Days)	61,143

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jamjoom Pharmaceuticals Factory Company had revenue of SAR 1.27 billion and earned 349.40 million in profits. Earnings per share was 4.99.

Revenue	1.27B
Gross Profit	778.81M
Operating Income	371.26M
Pretax Income	371.30M
Net Income	349.40M
EBITDA	404.94M
EBIT	371.26M
Earnings Per Share (EPS)	4.99

Balance Sheet

The company has 121.82 million in cash and 2.13 million in debt, giving a net cash position of 119.69 million or 1.71 per share.

Cash & Cash Equivalents	121.82M
Total Debt	2.13M
Net Cash	119.69M
Net Cash Per Share	1.71
Equity (Book Value)	1.44B
Book Value Per Share	20.64
Working Capital	782.39M

Cash Flow

In the last 12 months, operating cash flow was 310.11 million and capital expenditures -55.48 million, giving a free cash flow of 254.63 million.

Operating Cash Flow	310.11M
Capital Expenditures	-55.48M
Free Cash Flow	254.63M
FCF Per Share	3.64

Margins

Gross margin is 61.43%, with operating and profit margins of 29.28% and 27.56%.

Gross Margin	61.43%
Operating Margin	29.28%
Pretax Margin	29.29%
Profit Margin	27.56%
EBITDA Margin	31.94%
EBIT Margin	29.28%
FCF Margin	20.09%

Dividends & Yields

This stock pays an annual dividend of 3.20, which amounts to a dividend yield of 2.12%.

Dividend Per Share	3.20
Dividend Yield	2.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	62.11%
Buyback Yield	n/a
Shareholder Yield	2.12%
Earnings Yield	3.30%
FCF Yield	2.41%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jamjoom Pharmaceuticals Factory Company has an Altman Z-Score of 16.43.

Altman Z-Score	16.43
Piotroski F-Score	n/a